自动化主动学习优化水凝药物释放概况.
Eugene Cheong1, D Christopher Radford1, Adam J Gormley1
1Department of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
概括
这项研究引入了一种自动化,机器学习 (ML) 引导的框架,以优化酸盐水凝配方用于药物输送. ML方法显著加快了用于治疗的受控释放系统的发展.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 计算化学的计算化学
背景情况:
- 水凝提供了卓越的生物相容性和可调节的释放动力学,用于治疗.
- 优化凝配方针对特定的药物释放特征是传统上耗时和劳动密集的.
研究的目的:
- 开发一个自动化,高吞吐量和机器学习 (ML) 引导的框架,以实现高效的酸盐凝配方优化.
- 为了加快对敏感治疗药物的控制释放系统的设计.
主要方法:
- 使用液体处理机器人创建了120种含牛血清白蛋白 (BSA) 的酸盐水凝配方的多样化图书馆.
- 采用高斯过程回归 (GPR) ML模型来预测随着时间的推移累积释放配置文件.
- 应用沙普利添加剂解释 (SHAP) 进行特征重要性分析,以确定关键的释放动力学因素.
- 实施贝叶斯优化和主动学习,用于代的配方选择和改进.
主要成果:
- 确定了阿尔金酸盐分子量,度和时间作为影响药物释放动态的关键因素.
- 通过代的ML引导优化实现了接近零顺序的释放配置文件.
- 成功翻译了优化的配方,以实现长期释放的chondroitinase ABC单酶纳米颗粒 (chABC-SENs).
结论:
- 展示了一个可扩展的,数据驱动的战略,用于快速优化水凝配方.
- 强调了ML在加速先进可控释放技术发展方面的巨大潜力.
- 验证了该框架在优化释放复杂的治疗有效载荷 (如酶纳米粒子) 的有效性.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...


